George Tidmarsh has resigned as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research ...
The U.S. FDA once again has a leadership gap at the top of its drug center, which already has been ravaged this year by massive terminations, resignations and retirements of senior leaders. George ...
Head of FDA’s drug center George Tidmarsh is the latest member to see his name in headlines. On Friday, October 31, FDA ...
George Tidmarsh’s short run directing the agency’s principal drug review office reportedly ended in controversy. Elsewhere, ...
Tidmarsh, who was named as director of the Center for Drug Evaluation and Research (CDER) in July, told ABC in an interview ...
Stocktwits on MSN
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’
The development comes shortly after George Tidmarsh took a potshot against Aurinia Pharma’s kidney inflammation drug in a now ...
FDA CDER Director George Tidmarsh resigns over controversy involving Aurinia Pharma board chair and lupus drug criticism. Read more here.
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...
The top drug regulator at the Food and Drug Administration resigned on Sunday after it was revealed he undertook a "revenge campaign" against a former colleague, according to a new report. Dr. George ...
George Tidmarsh, a biopharma industry veteran who’s helmed CDER for a little more than three months, resigned yesterday after being placed on administrative leave two days earlier amid a Health and ...
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback